-
Mashup Score: 0
Phil Koo, MD is joined by Wolfgang Weber, MD sharing his thoughts on the current state of PSMA based therapies. Dr. Weber discusses which patients respond well to this treatment, as well as the research being done to better understand why some patients do not respond well to this treatment. Dr. Weber concludes with a glimpse of things to come for PSMA based therapies. Biographies: Wolfgang…
Source: UroTodayCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
Phil Koo, MD, and Wolfgang Weber, MD, to share his thoughts on the current state of PSMA based therapies. Dr. Weber discusses which patients respond well to this treatment, as well as the research being done to better understand why some patients do not respond well to this treatment. Dr. Weber concludes with a glimpse of things to come for PSMA based therapies. Biographies: Wolfgang Weber, MD…
Source: UroTodayCategories: Latest Headlines, UrologyTweet-
Targeted radionuclide therapy of #ProstateCancer. Wolfgang Weber, MD @TU_Muenchen joins @PhillipKooMD sharing his thoughts on the state of #PSMA based therapies. #WartchNow on UroToday > https://t.co/3Tq9RcLc5k @ASCO #GU20 https://t.co/idQsEZmKog
-
-
Mashup Score: 0
Phil Koo, MD, and Wolfgang Weber, MD, to share his thoughts on the current state of PSMA based therapies. Dr. Weber discusses which patients respond well to this treatment, as well as the research being done to better understand why some patients do not respond well to this treatment. Dr. Weber concludes with a glimpse of things to come for PSMA based therapies. Biographies: Wolfgang Weber, MD…
Source: UroTodayCategories: Latest Headlines, UrologyTweet-
Targeted radionuclide therapy of #ProstateCancer. Wolfgang Weber, MD @TU_Muenchen joins @PhillipKooMD sharing his thoughts on the state of #PSMA based therapies. #WartchNow on UroToday > https://t.co/3Tq9RcLc5k @ASCO #GU20 https://t.co/mjZrxXF9GT
-
Targeted radionuclide therapy of #ProstateCancer. Wolfgang Weber, MD @TU_Muenchen joins @PhillipKooMD sharing his thoughts on the state of #PSMA based therapies. #WartchNow on UroToday > https://t.co/3Tq9RcLc5k @ASCO #GU20 https://t.co/YRUztSyTGh